24/7 Patient Assistance: 760-405-8205

Michael Koontz, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

VA Palo Alto Health Care System Stanford Health Care-Stanford Hospital

specialties & services

Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy

  • Bio & Insurance Information
  • Education & Training

    dept_icon

    University of California Irvine

    Medical School

    dept_icon

    Stanford University

    Residency

    dept_icon

    Stanford University

    Fellowship

  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Stanford Health Care-Stanford Hospital

    Languages: English/Spanish

    (650) 723–4000

    300 Pasteur Drive

    Stanford, California 94304-1125

    Read More

    VA Palo Alto Health Care System

    Languages: English/Spanish

    (650) 493-5000

    3801 Miranda Ave

    Palo Alto, California 94304

    Read More
  • Publications & Memberships

    Dr. Michael Koontz has contributed to 3 publications.

    Nelarabine neurotoxicity with concurrent intrathecal chemotherapy: Case report and review of literature.

    Ngo, D.,Patel, S.,Kim, E. J.,Brar, R.,Koontz, M. Z.; J Oncol Pharm Pract. 2014 Mar 26.

    See more >>

    Risk of therapy-related secondary leukemia in hodgkin lymphoma: the stanford university experience over three generations of clinical trials.

    Koontz, M. Z.,Horning, S. J.,Balise, R.,Greenberg, P. L.,Rosenberg, S. A.,Hoppe, R. T.,Advani, R. H.; J Clin Oncol. 2013 Feb 10.

    See more >>

    Neoadjuvant Imatinib for Borderline Resectable GIST.

    Koontz, M. Z., Visser, B. M., Kunz, P. L.; J Natl Compr Canc Netw. 2012 Dec 1.

    See more >>